Vijaya Diagnostic Centre Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹255 Cr +26.2% YoYSee revenue, profit and what management said. You are viewing Q1 FY26.
VD

Vijaya Diagnostic Centre Ltd

Q1 FY26Healthcare Services

Vijaya Diagnostic Centre Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹188Cr
+20.5% YoY
+8.7% QoQ
Net profit
₹39Cr
+21.9% YoY
+11.4% QoQ
Margin
39%
0 pp YoY
−1 pp QoQ
Price₹1,504
Market cap₹14.3K Cr
P/E82.7

The short version

Vijaya Diagnostic targets consistent revenue growth of 15%+ annually, backed by about 13% volume growth. The company maintains a consistent revenue growth guidance of 15%+ annually, driven primarily by volume growth (~13%) and price increases (1.5%-2%).

From Vijaya Diagnostic Centre Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Vijaya Diagnostic targets consistent revenue growth of 15%+ annually, backed by about 13% volume growth.
  • Price increases contribute approximately 1.5% to 2% of the revenue growth.
  • Existing (old) centers are expected to continue growing test volumes by around 9%-10%.
  • New centers contribute the remaining volume growth, with rapid ramp-up seen in newly entered markets like East India and Bangalore.
  • The company aims to expand revenue in new geographies (e.g., East India) to Rs. 50-100 crore within 2-3 years through opening hubs and spokes.
  • Growth is driven by market share gains, increased patient footfalls, and expansion into new regions.

2 more points from Vijaya Diagnostic Centre Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Vijaya Diagnostic Centre Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • For FY26, guided overall CAPEX for new centers is around Rs. 150-155 crores.
  • Replacement CAPEX expected at 2%-3% of overall topline.
  • Five new hubs have been commissioned in the current quarter; five more hubs planned for the next two quarters.
  • Scouting for new locations across core and new geographies (including Bangalore, Kolkata, Pune) is ongoing.

2 more points from Vijaya Diagnostic Centre Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Vijaya Diagnostic Centre Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Vijaya Diagnostic Centre Ltd said on order book & pipeline — free account, 30 seconds.

Vijaya Diagnostic Centre Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Vijaya Diagnostic Centre Ltd Q1 FY26 results — key figures

Vijaya Diagnostic Centre Ltd Q1 FY26 reported results vs Q1 FY25, ₹ crore
₹ CrQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue188156+20.5%173+8.7%
Operating profit (EBITDA)7461+21.3%69+7.2%
Operating margin39%39%0 pp40%-1 pp
Profit before tax5242+23.8%47+10.6%
Net profit (PAT)3932+21.9%35+11.4%
EPS (₹)3.763.06+22.9%3.40+10.6%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹255 Cr, net profit ₹59 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Aster DM Quality (Q1 FY26)

    Recent quarters saw subdued volume growth due to leadership changes and seasonal effects, but an 8% volume growth was achieved in Q1 FY26, improving from 2% in…

  • Dr Agarwal's Hea (Q1 FY26)

    70 crores via preferential allotment to AEHL for CAPEX plans, particularly the flagship facility at Cathedral Road, indicating capacity and service…

  • Syngene International (Q1 FY26)

    Operating EBITDA grew 21% YoY in Q1 FY '26 with margins rising to ~24% from 22% last year. Key concall takeaways from Syngene International Ltd's Q1 FY26…

  • Yatharth Hospital & Trauma Care Services (Q1 FY26)

    International patient business is growing but will remain around 10% of revenue, positively impacting ARPOB without hurting margins. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Vijaya Diagnostic Centre Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Vijaya Diagnostic Centre Ltd Q1 FY26 results?

Vijaya Diagnostic targets consistent revenue growth of 15%+ annually, backed by about 13% volume growth. The company maintains a consistent revenue growth guidance of 15%+ annually, driven primarily by volume growth (~13%) and price increases (1.5%-2%).

What is Vijaya Diagnostic Centre Ltd share price analysis?

Vijaya Diagnostic Centre Ltd currently shows a neutral. The stock trades at a P/E of 82.7 with a market cap of ₹14,313 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vijaya Diagnostic Centre Ltd planning capital expenditure?

For FY26, guided overall CAPEX for new centers is around Rs. 150-155 crores.

Keep Vijaya Diagnostic Centre Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.